Didier Delanoye

Didier is Lead Partner for alternative delivery models (ADMs) within PwC Belgium. He has over 24 years of external audit experience working mainly with European and US multinationals, with a focus on Biotech, Pharma and Medical Device companies. He completed a two-year secondment to the UK in June 2012, working mainly with a large pharmaceutical company and supporting PwC in undertaking its audit transformation programme.

Didier also has significant experience in shared audit comfort models and using data auditing techniques. He provides accounting and financial advice related to capital market transactions, mergers and acquisitions, option plans, (re)structuring and group reorganisations and has substantial experience in auditing and advising on internal control matters (including Sarbanes-Oxley) and implementing shared service centres.

Didier was a key driver in the outsourcing of audit work to the different delivery centres across the PwC Network, with a particular focus on standardisation and efficiency. He’s responsible for managing PwC partnerships with Pharma & Life Science organisations such as flanders.bio, BioWin, Pharma.be and Medvia.